Skip to Main Content

Paper Details

Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease.
Front Endocrinol (Lausanne)
6
2023
Author NameAffiliation
Nikolaos E BechrakisUniversity Hospital Essen, University Duisburg-Essen
Gary D HammerUniversity of Michigan ann arbor
  • 1 - 2

Datasets

Release 1.2